|
|
|
Volumn 2, Issue 4, 2002, Pages 129-137
|
|
The development of new medical treatments for acute decompensated heart failure.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRAIN NATRIURETIC PEPTIDE;
CARDIOTONIC AGENT;
ENDOTHELIN RECEPTOR;
HYDRAZONE DERIVATIVE;
NATRIURETIC FACTOR;
PLACEBO;
PYRIDAZINE DERIVATIVE;
PYRIDINE DERIVATIVE;
SIMENDAN;
TETRAZOLE DERIVATIVE;
TEZOSENTAN;
VASODILATOR AGENT;
ACUTE DISEASE;
CLINICAL TRIAL;
COHORT ANALYSIS;
COMPARATIVE STUDY;
CONGESTIVE HEART FAILURE;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
HEMODYNAMICS;
HUMAN;
MORTALITY;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TIME;
ACUTE DISEASE;
CARDIOTONIC AGENTS;
COHORT STUDIES;
HEART FAILURE, CONGESTIVE;
HEMODYNAMIC PROCESSES;
HUMANS;
HYDRAZONES;
MULTICENTER STUDIES;
NATRIURETIC AGENTS;
NATRIURETIC PEPTIDE, BRAIN;
PLACEBOS;
PYRIDAZINES;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS;
RECEPTORS, ENDOTHELIN;
TETRAZOLES;
TIME FACTORS;
VASODILATOR AGENTS;
|
|
EID: 0036985806
PISSN: 14708590
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (48)
|
